Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Hepatosplenic T Cell Lymphoma: A Rare Case Report

Authors: Monalisa Hui, Shantveer G. Uppin, Tara Roshni Paul, N. Beerappa

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

Hepatosplenic T cell lymphoma is a rare form of extra nodal and systemic neoplasm derived from cytotoxic T cells and represents less than 1 % of all non Hodgkins lymphoma. Here we present a case of hepatosplenic T cell lymphoma in a 30 year old male who presented with icterus, pancytopenia and hepatosplenomegaly, highlighting the diagnostic conundrum and pointers towards an accurate diagnosis. Histologically the sinusoids of liver and splenic red pulp were infiltration by CD 3 positive neoplastic lymphoid cells. The pattern of marrow involvement was very subtle and diagnosis was difficult to establish without the help of immunohistochemistry. This case highlights the importance of considering hepatosplenic T cell lymphoma as differential diagnosis in the clinical setting of pancytopenia with hepatosplenomegaly to allow timely diagnosis of these aggressive neoplasms.
Literature
1.
go back to reference Farcet JP, Gaulard P, Marolleau JP, Le Couedic JP, Henni T, Gourdin MF et al (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75:2213–2219PubMed Farcet JP, Gaulard P, Marolleau JP, Le Couedic JP, Henni T, Gourdin MF et al (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75:2213–2219PubMed
2.
go back to reference Falchook GS, Vega F, Dang NH, Samaniego F, Rodriguez MA, Champlin RE, Hosing C, Verstovsek S, Pro B (2009) Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 20:1080–1085PubMedCrossRefPubMedCentral Falchook GS, Vega F, Dang NH, Samaniego F, Rodriguez MA, Champlin RE, Hosing C, Verstovsek S, Pro B (2009) Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 20:1080–1085PubMedCrossRefPubMedCentral
3.
go back to reference Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al (1994) A revised European American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al (1994) A revised European American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed
5.
go back to reference Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW et al (1996) Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88:4265–4274PubMed Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW et al (1996) Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88:4265–4274PubMed
6.
go back to reference Sadahira Y, Ohmoto K, Yamamoto S, Nishihara H, Wada H, Yawata Y et al (1998) Expression of cytotoxic molecule TIA-1 in malignant lymphomas mimicking fulminant hepatitis. Pathol Int 48:695–704PubMedCrossRef Sadahira Y, Ohmoto K, Yamamoto S, Nishihara H, Wada H, Yawata Y et al (1998) Expression of cytotoxic molecule TIA-1 in malignant lymphomas mimicking fulminant hepatitis. Pathol Int 48:695–704PubMedCrossRef
7.
go back to reference Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R et al (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102:4261–4269PubMedCrossRef Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R et al (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102:4261–4269PubMedCrossRef
8.
go back to reference Lu CL, Tang Y, Yang QP, Wang M, Zhao S, Bi CF, Jiang NG, Zhang WY, Liu JP, Xu X, Liu WP (2011) Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases. Hum Pathol 42:1965–1978PubMedCrossRef Lu CL, Tang Y, Yang QP, Wang M, Zhao S, Bi CF, Jiang NG, Zhang WY, Liu JP, Xu X, Liu WP (2011) Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases. Hum Pathol 42:1965–1978PubMedCrossRef
9.
go back to reference Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R et al (2001) Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116:410–419PubMedCrossRef Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R et al (2001) Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116:410–419PubMedCrossRef
10.
go back to reference Weidmann E (2000) Hepatosplenic T Cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 14:991–997PubMedCrossRef Weidmann E (2000) Hepatosplenic T Cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 14:991–997PubMedCrossRef
11.
go back to reference Gaulard P, Kanavaros P, Farcet JP, Rocha FD, Haioun C, Divine M et al (1991) Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: a study of 38 cases. Hum Pathol 22:331–338PubMedCrossRef Gaulard P, Kanavaros P, Farcet JP, Rocha FD, Haioun C, Divine M et al (1991) Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: a study of 38 cases. Hum Pathol 22:331–338PubMedCrossRef
Metadata
Title
Hepatosplenic T Cell Lymphoma: A Rare Case Report
Authors
Monalisa Hui
Shantveer G. Uppin
Tara Roshni Paul
N. Beerappa
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-012-0219-y

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine